Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deedra Nicolet

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Cancer Research|October 28, 2016
Mutational Landscape and Gene Expression Patterns in Adult Acute Myeloid Leukemias with Monosomy 7 as a Sole AbnormalityAnn-Kathrin Eisfeld, Jessica Kohlschmidt, Krzysztof Mrózek, et al.
Leukemia|August 8, 2020
Comparison of clinical and molecular characteristics of patients with acute myeloid leukemia and either TP73 or TP53 mutationsAlice S Mims, Jessica Kohlschmidt, Ann-Kathrin Eisfeld, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2024
<i>circPCMTD1</i> : A protein-coding circular RNA that regulates DNA damage response in <i>BCR/ABL</i> -positive leukemiasDimitrios Papaioannou, Amog P Urs, Rémi Buisson, et al.
Journal of Hematology & Oncology|July 7, 2021
Precision oncology in AML: validation of the prognostic value of the knowledge bank approach and suggestions for improvementMarius Bill, Krzysztof Mrózek, Brian Giacopelli, et al.
Leukemia|August 30, 2019
Clinical and molecular characterization of patients with acute myeloid leukemia and sole trisomies of chromosomes 4, 8, 11, 13 or 21Bhavana Bhatnagar, Ann-Kathrin Eisfeld, Jessica Kohlschmidt, et al.
American Journal of Hematology|September 16, 2024
White blood cell count levels are associated with inflammatory response and constitute independent outcome predictors in adult patients with acute myeloid leukemia aged <60 yearsMichael Ozga, Deedra Nicolet, Krzysztof Mrózek, et al.
Leukemia|May 29, 2020
Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 yearsAnn-Kathrin Eisfeld, Jessica Kohlschmidt, Alice Mims, et al.
American Journal of Hematology|January 31, 2017
Prognostic impact of the CD34+/CD38- cell burden in patients with acute myeloid leukemia receiving allogeneic stem cell transplantationMadlen Jentzsch, Marius Bill, Deedra Nicolet, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 6, 2020
Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/<i>KMT2A</i>Marius Bill, Krzysztof Mrózek, Jessica Kohlschmidt, et al.
Leukemia|March 23, 2018
Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: an analysis of Alliance studiesAnn-Kathrin Eisfeld, Jessica Kohlschmidt, Krzysztof Mrózek, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Cancer Research|October 28, 2016
Mutational Landscape and Gene Expression Patterns in Adult Acute Myeloid Leukemias with Monosomy 7 as a Sole AbnormalityAnn-Kathrin Eisfeld, Jessica Kohlschmidt, Krzysztof Mrózek, et al.
Leukemia|August 8, 2020
Comparison of clinical and molecular characteristics of patients with acute myeloid leukemia and either TP73 or TP53 mutationsAlice S Mims, Jessica Kohlschmidt, Ann-Kathrin Eisfeld, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2024
<i>circPCMTD1</i> : A protein-coding circular RNA that regulates DNA damage response in <i>BCR/ABL</i> -positive leukemiasDimitrios Papaioannou, Amog P Urs, Rémi Buisson, et al.
Journal of Hematology & Oncology|July 7, 2021
Precision oncology in AML: validation of the prognostic value of the knowledge bank approach and suggestions for improvementMarius Bill, Krzysztof Mrózek, Brian Giacopelli, et al.
Leukemia|August 30, 2019
Clinical and molecular characterization of patients with acute myeloid leukemia and sole trisomies of chromosomes 4, 8, 11, 13 or 21Bhavana Bhatnagar, Ann-Kathrin Eisfeld, Jessica Kohlschmidt, et al.
American Journal of Hematology|September 16, 2024
White blood cell count levels are associated with inflammatory response and constitute independent outcome predictors in adult patients with acute myeloid leukemia aged <60 yearsMichael Ozga, Deedra Nicolet, Krzysztof Mrózek, et al.
Leukemia|May 29, 2020
Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 yearsAnn-Kathrin Eisfeld, Jessica Kohlschmidt, Alice Mims, et al.
American Journal of Hematology|January 31, 2017
Prognostic impact of the CD34+/CD38- cell burden in patients with acute myeloid leukemia receiving allogeneic stem cell transplantationMadlen Jentzsch, Marius Bill, Deedra Nicolet, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 6, 2020
Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/<i>KMT2A</i>Marius Bill, Krzysztof Mrózek, Jessica Kohlschmidt, et al.
Leukemia|March 23, 2018
Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: an analysis of Alliance studiesAnn-Kathrin Eisfeld, Jessica Kohlschmidt, Krzysztof Mrózek, et al.
Pageof 8